Sutro Biopharma
STRO
#8442
Rank
C$0.22 B
Marketcap
$2.70
Share price
3.30%
Change (1 day)
-51.37%
Change (1 year)

Sutro Biopharma (STRO) - Cash on Hand

Cash on Hand as of September 2024 : C$0.55 Billion

According to Sutro Biopharma's latest financial reports the company has C$0.55 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sutro Biopharma - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$0.45 B79.86%
2021-12-31C$0.25 B-46.26%
2020-12-31C$0.46 B204.93%
2019-12-31C$0.15 B-44.74%
2018-12-31C$0.27 B906.19%
2017-12-31C$27.68 M-56.65%
2016-12-31C$63.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$23.54 M-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.58 B 4.67%๐Ÿ‡บ๐Ÿ‡ธ USA